Inhibrx Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 05/15/2025 | 1.79 M | $25.01 M | 0.00% | 11.56% |
| SANOFI | 05/06/2025 | 1.16 M | $16.20 M | 0.00% | 7.49% |
| PERCEPTIVE ADVISORS LLC | 05/15/2025 | 1.06 M | $14.89 M | 0.00% | 7.35% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2025 | 697.92 K | $9.76 M | 32.38% | 4.82% |
| PFM HEALTH SCIENCES, LP | 05/15/2025 | 439.28 K | $6.15 M | 224.08% | 3.03% |
| WOODLINE PARTNERS LP | 05/15/2025 | 358.44 K | $5.01 M | 100.00% | 2.32% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 255.34 K | $3.57 M | -1.18% | 1.76% |
| CAPTION MANAGEMENT, LLC | 05/15/2025 | 199.51 K | $2.79 M | -0.20% | 1.29% |
| ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 192.50 K | $2.69 M | 34.17% | 1.24% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2025 | 144.18 K | $2.02 M | 0.00% | 0.93% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2025 | 139.68 K | $1.95 M | -13.19% | 0.90% |
| 05/15/2025 | 64.22 K | $898.40 K | 0.00% | 0.44% | |
| QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 47.91 K | $670.22 K | -47.48% | 0.31% |
| IKARIAN CAPITAL, LLC | 05/15/2025 | 42.12 K | $589.29 K | 0.00% | 0.29% |
| TABOR ASSET MANAGEMENT, LP | 05/05/2025 | 36.20 K | $506.37 K | 100.00% | 0.23% |
| MURCHINSON LTD. | 05/15/2025 | 33.79 K | $472.72 K | 0.00% | 0.23% |
| BIRCHVIEW CAPITAL, LP | 05/15/2025 | 32.11 K | $449.22 K | 0.00% | 0.22% |
| BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 28.23 K | $394.94 K | 0.00% | 0.18% |
| 05/12/2025 | 25.02 K | $350.04 K | 100.00% | 0.16% | |
| MARINER, LLC | 05/15/2025 | 18.67 K | $261.15 K | 100.00% | 0.12% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 6.97 K | $97.44 K | 4.69% | 0.05% |
| 05/09/2025 | 3.37 K | $47.20 K | 0.00% | 0.02% | |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 04/30/2025 | 2.90 K | $40.63 K | -5.38% | 0.02% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 04/24/2025 | 488 | $6.89 K | 1.24% | 0.00% |
| VERSANT CAPITAL MANAGEMENT, INC | 04/03/2025 | 396 | $5.54 K | 100.00% | 0.00% |
| CORECAP ADVISORS, LLC | 05/09/2025 | 18 | $252 | 100.00% | 0.00% |
| PEKIN HARDY STRAUSS, INC. | 04/30/2025 | 0 | $0 | -100.00% | 0.00% |
| CSS LLC/IL | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| MARSHALL WACE, LLP | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| GSA CAPITAL PARTNERS LLP | 05/08/2025 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE TRADING LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| CREATIVE PLANNING | 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
| 05/13/2025 | 0 | $0 | -100.00% | 0.00% | |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | 04/21/2025 | 0 | $0 | -100.00% | 0.00% |
| QUADRANT CAPITAL GROUP LLC | 05/13/2025 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LINDBROOK CAPITAL, LLC | 05/05/2025 | 0 | $0 | -100.00% | 0.00% |
| QUEST PARTNERS LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
| 05/15/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Inhibrx Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 45 institutional investors and hedge funds held shares of Inhibrx Biosciences, Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 1.06 M
Sofinnova Investments, Inc.: 697,916
PFM Health Sciences, LP: 439,283
MILLENNIUM MANAGEMENT LLC: 255,336
Ikarian Capital, LLC: 42,122
Murchinson Ltd.: 33,790
18.34% of Inhibrx Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 3.84 M shares in the last 24 months. This purchase volume represents approximately $50.51 M in transactions.